NCT00314743View on ClinicalTrials.gov

Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

NauseaVomiting

Interventions

DRUG

Ondansetron

DRUG

Dexamethasone

DRUG

Aprepitant

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT00314743 - Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation | Biotech Hunter | Biotech Hunter